Article info
PDFOriginal article
Elevated levels of autophagy-related marker ULK1 and mitochondrion-associated autophagy inhibitor LRPPRC are associated with biochemical progression and overall survival after androgen deprivation therapy in patients with metastatic prostate cancer
- Correspondence to Dr Zi-Ming Wang, Department of Urology, The Second Affiliated Hospital, Xi'an Jiaotong University, No. 157 Westwu Road, Xi'an 710004, Shaanxi Province, People's Republic of China; zi_ming_wang{at}126.com Jie Cui, Department of Oncology, The First Affiliated Hospital, Xi'an Jiaotong University No. 277 Yanta West Road, Xi'an 710061, Shaanxi Province People's Republic of China cuicui780204{at}163.com
Citation
Elevated levels of autophagy-related marker ULK1 and mitochondrion-associated autophagy inhibitor LRPPRC are associated with biochemical progression and overall survival after androgen deprivation therapy in patients with metastatic prostate cancer
Publication history
- Received June 8, 2016
- Revised September 1, 2016
- Accepted September 4, 2016
- First published September 27, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/